Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo


Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

Delivering electrical stimulation to the spinal cord through tiny, platinum electrodes could ease the severe motor deficits of Parkinson’s disease as effectively as a much more intrusive procedure currently in clinical use, according to a new study in rodents. If the findings are confirmed in humans, scientists say, the procedure could dramatically improve treatment for the disease by making electrical therapies safer and more broadly available.

Parkinson’s is a neurodegenerative disorder that develops when the brain cells that produce, excrete, and reabsorb a neurotransmitter called dopamine mysteriously begin to die. Patients initially develop muscle tremors; in the later stages of the disease, their limbs go rigid, and their movements slow to a painful crawl. The disease can be treated by replacing dopamine with a drug called levodopa, or L-dopa, but the drug loses its effectiveness over time. When drugs fail, patients often turn to an invasive surgical treatment called deep brain stimulation, which uses an electric pacemaker to send pulses to very specific areas of the brain. Thousands of Parkinson’s patients have received the brain implants to date.

Researchers at Duke University accidently came upon the idea of stimulating the spinal cord as a possible treatment for Parkinson’s. While examining rats engineered to exhibit symptoms characteristic of Parkinson’s, they noticed that groups of neurons in two areas of the brain, the cortex and the basal ganglia, were firing synchronously. The rhythmic activity was reminiscent of the mild, continuous seizures seen in patients with epilepsy. “I had seen this a decade ago,” says Miguel Nicolelis, a professor of neurobiology and codirector of the Center for Neuroengineering at Duke University. At the time, Nicolelis and his collaborators were searching for ways to disrupt rhythmic seizures by stimulating peripheral nerves.

Nicolelis reasoned that a similar approach might work for Parkinson’s. So he and his student Romulo Fuentes took their dopamine-depleted mice and rats and attached tiny platinum electrodes to the base of their spinal cords. “When we stimulated them with a small current, we got an effect that was identical–and even better–than what people get when they do this deep brain stimulation,” Nicolelis says. The Parkinsonian animals’ slow stiff movements were replaced with healthy mouse and rat behaviors.

When Nicolelis and Fuentes combined the electrical stimulation with L-dopa, the effects were even more startling. The electric pulses, combined with only 20 percent of the typical drug dose, resulted in a long-term effect that mimicked L-dopa therapy without appearing to replicate the drug resistance that normally builds up over time. The research was published yesterday in the journal Science.

1 comment. Share your thoughts »

Credit: Romulo Fuentes

Tagged: Biomedicine, Parkinson's, electrode, neurotechnology, electrical stimulation, spinal cord therapy

Reprints and Permissions | Send feedback to the editor

From the Archives


Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me